Structure-activity relationship of C4-substituted pyrimidopyrimidines; Dual KDR/FGFR tyrosine kinase inhibitors.

被引：0
|
作者：
Rossman, P
Luk, K
Chen, Y
Garafalo, L
Graves, B
Jackson, N
Kabat, M
Konzelmann, F
Liu, JJ
Lukacs, C
McDermott, L
Michoud, C
Portland, L
Roberts, J
Schutt, A
Simcox, M
So, SS
Tamborini, B
Yang, H
机构：
[1] Hoffmann La Roche Inc, Discovery Chem, Nutley, NJ 07110 USA
[2] Hoffmann La Roche Inc, Chem Synth, Nutley, NJ 07110 USA
[3] Hoffmann La Roche Inc, Discovery Oncol, Nutley, NJ 07110 USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2005年 / 229卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
124-MEDI
引用
收藏
页码：U129 / U129
页数：1
相关论文
共 50 条
  • [21] Design, synthesis and structure-activity relationship of HIV-1 integrase inhibitors.
    Zhao, H
    Neamati, N
    Mazumder, A
    Pommier, Y
    Burke, TR
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1996, 212 : 21 - MEDI
  • [22] Structure-activity relationship study of novel tissue transglutaminase (TGase 2) inhibitors.
    Duval, E
    Case, A
    Stein, RL
    Cuny, GD
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 229 : U144 - U144
  • [23] The synthesis and structure activity relationship of substituted oxazolone analogs as amyloid aggregation inhibitors.
    Sakkab, AT
    Augelli-Szafran, CE
    Kimura, T
    Levine, H
    McClure, C
    Tasaki, Y
    Yasunaga, T
    Ye, YY
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U49 - U49
  • [24] Synthesis and structure activity relationship of substituted isoindoline analogs as amyloid aggregation inhibitors.
    Sakkab-Tan, AT
    Augelli-Szafran, CE
    Choi, C
    Lai, YJ
    Levine, H
    Milbank, J
    Orahovats, P
    Yasunaga, T
    Ye, YY
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 229 : U144 - U144
  • [25] Quantitative Structure-Activity Relationship Analysis of 4(3H)-Quinazolone Derivatives as Tyrosine Kinase Inhibitors by Multiple Linear Regression
    Srivastava, Vikas
    Sinha, Deepa
    Tiwari, Anjani K.
    Sharma, Himanshu
    Sharma, Raj Bala
    Singh, Vinay K.
    Mishra, Anil K.
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2010, 25 (05) : 559 - 562
  • [26] Structure-activity relationship of 7-aryl-2-anilino-pyrrolopyrimidines as Mer and Axl tyrosine kinase inhibitors
    Chung, Shin Hyuck
    Park, Jiwon
    Lee, Jung Wuk
    Song, Jiho
    Jung, Danbee
    Min, Kyung Hoon
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2020, 35 (01) : 1822 - 1833
  • [27] Synthesis and structure-activity relationship of ribofuranosyl echiguanine analogs as inhibitors of phosphatidylinositol 4-kinase
    Saito, Y
    Kato, K
    Umezawa, K
    TETRAHEDRON, 1998, 54 (17) : 4251 - 4266
  • [28] α-Bromoacetophenone derivatives as neutral protein tyrosine phosphatase inhibitors:: Structure-activity relationship
    Arabaci, G
    Yi, T
    Fu, H
    Porter, ME
    Beebe, KD
    Pei, DH
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (21) : 3047 - 3050
  • [29] Design, synthesis, and structure-activity relationships of substituted aniline-based factor Xa inhibitors.
    Huang, WR
    Zhang, PL
    Song, YH
    Wong, P
    Tran, K
    Sinha, U
    Scarborough, RM
    Zhu, BY
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 219 : U131 - U131
  • [30] Structure-activity studies of 5-substituted pyridopyrimidines as adenosine kinase inhibitors
    Cowart, M
    Lee, CH
    Gfesser, GA
    Bayburt, EK
    Bhagwat, SS
    Stewart, AO
    Yu, HX
    Kohlhaas, KL
    McGaraughty, S
    Wismer, CT
    Mikusa, J
    Zhu, C
    Alexander, KM
    Jarvis, MF
    Kowaluk, EA
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (01) : 83 - 86
12345